AR122365A1 - Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria - Google Patents
Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamariaInfo
- Publication number
- AR122365A1 AR122365A1 ARP210100104A ARP210100104A AR122365A1 AR 122365 A1 AR122365 A1 AR 122365A1 AR P210100104 A ARP210100104 A AR P210100104A AR P210100104 A ARP210100104 A AR P210100104A AR 122365 A1 AR122365 A1 AR 122365A1
- Authority
- AR
- Argentina
- Prior art keywords
- veterinary composition
- intramamary
- prolactin
- administration
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 241000282849 Ruminantia Species 0.000 title abstract 4
- 230000001263 anti-prolactin effect Effects 0.000 title 1
- 235000013365 dairy product Nutrition 0.000 abstract 3
- 239000008267 milk Substances 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- KORNTPPJEAJQIU-KJXAQDMKSA-N Cabaser Chemical compound C1=CC([C@H]2C[C@H](CN(CC=C)[C@@H]2C2)C(=O)N(CCCN(C)C)C(=O)NCC)=C3C2=CNC3=C1 KORNTPPJEAJQIU-KJXAQDMKSA-N 0.000 abstract 1
- 229960004596 cabergoline Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20305066 | 2020-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR122365A1 true AR122365A1 (es) | 2022-09-07 |
Family
ID=69528716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210100104A AR122365A1 (es) | 2020-01-27 | 2021-01-15 | Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20230063100A1 (https=) |
| EP (1) | EP4096428B1 (https=) |
| JP (1) | JP7624999B2 (https=) |
| KR (1) | KR20220132561A (https=) |
| CN (1) | CN115003164A (https=) |
| AR (1) | AR122365A1 (https=) |
| AU (1) | AU2021213891A1 (https=) |
| BR (1) | BR112022014708A2 (https=) |
| CA (1) | CA3165962A1 (https=) |
| ES (1) | ES2969031T3 (https=) |
| HU (1) | HUE064769T2 (https=) |
| IL (1) | IL294903A (https=) |
| MX (1) | MX2022009177A (https=) |
| UY (1) | UY39022A (https=) |
| WO (1) | WO2021151897A1 (https=) |
| ZA (1) | ZA202207808B (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526892A (en) | 1981-03-03 | 1985-07-02 | Farmitalia Carlo Erba, S.P.A. | Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas |
| FR2936710B1 (fr) * | 2008-10-07 | 2011-01-07 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| FR2971423B1 (fr) * | 2011-02-15 | 2014-01-10 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| CN106389964B (zh) * | 2016-11-21 | 2019-05-14 | 四川农业大学 | 一种奶牛回乳药物组合 |
| WO2019224149A1 (en) * | 2018-05-23 | 2019-11-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of an oral bolus in the drying-off of dairy cattle |
-
2021
- 2021-01-15 UY UY0001039022A patent/UY39022A/es not_active Application Discontinuation
- 2021-01-15 AR ARP210100104A patent/AR122365A1/es unknown
- 2021-01-26 AU AU2021213891A patent/AU2021213891A1/en active Pending
- 2021-01-26 ES ES21702016T patent/ES2969031T3/es active Active
- 2021-01-26 WO PCT/EP2021/051766 patent/WO2021151897A1/en not_active Ceased
- 2021-01-26 CA CA3165962A patent/CA3165962A1/en active Pending
- 2021-01-26 EP EP21702016.3A patent/EP4096428B1/en active Active
- 2021-01-26 HU HUE21702016A patent/HUE064769T2/hu unknown
- 2021-01-26 JP JP2022544228A patent/JP7624999B2/ja active Active
- 2021-01-26 CN CN202180010827.9A patent/CN115003164A/zh active Pending
- 2021-01-26 KR KR1020227028233A patent/KR20220132561A/ko active Pending
- 2021-01-26 MX MX2022009177A patent/MX2022009177A/es unknown
- 2021-01-26 US US17/793,324 patent/US20230063100A1/en active Pending
- 2021-01-26 BR BR112022014708A patent/BR112022014708A2/pt unknown
- 2021-01-26 IL IL294903A patent/IL294903A/en unknown
-
2022
- 2022-07-13 ZA ZA2022/07808A patent/ZA202207808B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4096428B1 (en) | 2023-10-11 |
| MX2022009177A (es) | 2022-08-17 |
| BR112022014708A2 (pt) | 2022-10-11 |
| CA3165962A1 (en) | 2021-08-05 |
| AU2021213891A1 (en) | 2022-08-18 |
| CN115003164A (zh) | 2022-09-02 |
| HUE064769T2 (hu) | 2024-04-28 |
| WO2021151897A1 (en) | 2021-08-05 |
| ES2969031T3 (es) | 2024-05-16 |
| IL294903A (en) | 2022-09-01 |
| JP7624999B2 (ja) | 2025-01-31 |
| JP2023511147A (ja) | 2023-03-16 |
| KR20220132561A (ko) | 2022-09-30 |
| EP4096428C0 (en) | 2023-10-11 |
| UY39022A (es) | 2021-07-30 |
| EP4096428A1 (en) | 2022-12-07 |
| US20230063100A1 (en) | 2023-03-02 |
| ZA202207808B (en) | 2023-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024001203A (es) | Combinaciones de agonistas de receptores de hormona tiroidea (tr-\03b2) con moduladores metabolicos para usarse en tratar enfermedades del higado graso. | |
| BR112022002392A2 (pt) | Formas em estado sólido de (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetra-hidronaftalen-2-il)amino)-n-(1-(2-metil-1)-(neopentilamino)propan-2-il)-1h-imidazol-4-il)pentanamida e seus usos | |
| JP2017517570A5 (https=) | ||
| RU2011118366A (ru) | Ветеринарная антипролактиновая композиция для жвачных | |
| CA2470168C (en) | Drink preparation comprising ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and pain in a herd of animals | |
| AR122365A1 (es) | Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria | |
| RU2015144027A (ru) | Способ предотвращения, уменьшения, облегчения или лечения идиопатической рвоты и композиция для его осуществления | |
| CL2020002843A1 (es) | Uso de un bolo oral en el secado de ganado lechero | |
| RU2016119285A (ru) | Кормовая добавка и способ ее применения в молочном животноводстве | |
| MX2017004651A (es) | Composiciones para incrementar la produccion de grasa lactea en rumiantes lactantes y metodos para utilizar las mismas. | |
| FR2971423B1 (fr) | Composition veterinaire antiprolactinique destinee aux ruminants | |
| BR102013016084B1 (pt) | Composição para o tratamento de hipocalcemia em animais ruminantes | |
| Sanyal | Plasma levels of fenbendazole metabolites in buffalo and cattle after long‐term intraruminal administration | |
| AR009362A1 (es) | Uso de metanamina para la manufactura de un medicamento para mejorar la digestion, crecimiento y metabolismo en animales, una composicion alimenticiapara animales que comprende metanamina y alimento convencional; un metodo para preservar un producto lacteo; y una composicion de producto lacteo que c | |
| AR122366A1 (es) | Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche | |
| Bakr et al. | Effect of Exogenous Progesterone in Treatment of Ovarian Inactivity in the Egyptian Dairy Parturient Buffalo-Cows. | |
| Velladurai et al. | Ovsynch protocol for improving oestrus and conception rate in retained fetal membrane (RFM) affected cows. | |
| Pickett et al. | 35 Effects of Supplementing Pre-and Pro-Biotic Feed Ingredients on Performance, Health, and Physiological Responses in Feedlot Cattle | |
| Kumar et al. | A comparative evaluation of two therapies for the management of acute bovine mastitis | |
| Patel et al. | ECONOMICS OF EARLY PROPHYLACTIC TREATMENT REGIMEN AT CALVING ON REPRODUCTIVE PERFORMANCE IN SURTI BUFFALOES | |
| AR126894A1 (es) | Composición farmacéutica de agonista de fxr y su método de preparación | |
| Musgrave et al. | Impact of pre-and postpartum nutrition on March-calving cow and progeny productivity | |
| Kermani Moakhar et al. | Comparing reproduction and production parameters in managing program of two and three birth times during two years using melatonin in ewes | |
| Sahatpure et al. | Prophylactic efficacy of Exapar N in prevention of post partum reproductive disorders in Nagpuri cattle | |
| Dias et al. | Deslorelin acetate to induce ovulation in mares. |